Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with an overall dismal prognosis. Although there has been progress in systemic therapies in the palliative and adjuvant setting [[1]Neoptolemos J.P. Kleeff J. Michl P. Costello E. Greenhalf W. Palmer D.H Therapeutic developments in pancreatic cancer: current and future perspectives.Nat Rev Gastroenterol Hepatol. 2018; 15: 333-348Crossref PubMed Scopus (544) Google Scholar], PDAC is...
Paper Details
Title
Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
Published Date
Dec 1, 2019
Journal
Volume
17
Pages
100222 - 100222
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History